Peter Anevski - 01 Sep 2022 Form 4 Insider Report for Progyny, Inc. (PGNY)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
06 Sep 2022, 16:22:20 UTC
Prior SEC filing
16 Aug 2022
Next SEC filing
09 Sep 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Mark Livingston, Attorney-in-Fact

Key filing fact

Peter Anevski filed Form 4 for Progyny, Inc. (PGNY) on 06 Sep 2022.

Key facts

  • This page summarizes Peter Anevski's Form 4 filing for Progyny, Inc. (PGNY).
  • 8 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 06 Sep 2022, 16:22.

Change

  • Previous filing in this sequence was filed on 16 Aug 2022.
  • Current net transaction value: -$723,618.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PGNY transaction

Common Stock

Options Exercise

Transaction value
$63,200
Shares
+16,000
Change %
+4.9%
Price
$3.95*
Shares after
340,916
Date
01 Sep 2022
Ownership
Direct
PGNY transaction

Common Stock

Sale

Transaction value
$623,680
Shares
-16,000
Change %
-4.7%
Price
$38.98
Shares after
324,916
Date
01 Sep 2022
Ownership
Direct
Footnotes
F1, F2
PGNY transaction

Common Stock

Sale

Transaction value
$155,920
Shares
-4,000
Change %
-2.8%
Price
$38.98
Shares after
138,126
Date
01 Sep 2022
Ownership
See footnote
Footnotes
F1, F2, F3
PGNY transaction

Common Stock

Options Exercise

Transaction value
$632
Shares
+160
Change %
+0.05%
Price
$3.95*
Shares after
325,076
Date
02 Sep 2022
Ownership
Direct
PGNY transaction

Common Stock

Sale

Transaction value
$6,280
Shares
-160
Change %
-0.05%
Price
$39.25
Shares after
324,916
Date
02 Sep 2022
Ownership
Direct
Footnotes
F1, F4
PGNY transaction

Common Stock

Sale

Transaction value
$1,570
Shares
-40
Change %
-0.03%
Price
$39.25
Shares after
138,086
Date
02 Sep 2022
Ownership
See footnote
Footnotes
F1, F3, F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PGNY transaction Derivative

Option (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-16,000
Change %
-1%
Price
$0.000000
Shares after
1,579,556
Date
01 Sep 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
16,000
Exercise price
$3.95
Footnotes
F5
PGNY transaction Derivative

Option (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-160
Change %
-0.01%
Price
$0.000000
Shares after
1,579,396
Date
02 Sep 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
160
Exercise price
$3.95
Footnotes
F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022.

Footnote F2

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.85 to $39.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F3

The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC.

Footnote F4

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.08 to $39.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F5

One-fourth (1/4th) of the shares subject to the Option vested on May 23, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .